Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today? - Wikidata - awgldk - TriplyDB

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

http://www.wikidata.org/entity/Q37957047

about

Human conditions of insulin-like growth factor-I (IGF-I) deficiency Growth hormone insensitivity: diagnostic and therapeutic approaches.

P2860

Q26822806-B4FF357E-712E-4C81-93C8-31B3224B63E5 Q38524183-05AD39CA-FF3D-4BF6-8354-883C1C9A135E

P2860

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

http://www.wikidata.org/entity/Q37957047

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

@en

Recombinant human IGF-1

@nl

type

label

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

@en

Recombinant human IGF-1

@nl

prefLabel

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

@en

Recombinant human IGF-1

@nl

P1433

Q37957047-ADA1D51E-0AC4-4AEC-BEDB-114CA0BF9065

P1476

Q37957047-43A872BC-9F3D-4CCA-A413-DEE61096C380

P2093

Q37957047-1E42CE9C-A47B-43F7-BF8C-690D77D9BB7A

Q37957047-4FDB856E-8146-472D-88A0-C980CA428394

P2860

Q37957047-0756AFA6-3037-485A-987D-A4ADC38985C0

Q37957047-09E6F5A0-748A-439D-A128-20819E20DBAC

Q37957047-114CF381-5D11-4A8B-8806-7CF8EA5222FD

Q37957047-2906BC30-8651-4319-A167-9D97B3D103DE

Q37957047-2BDD3E6F-838D-4932-AAE7-DF38DF3CA6C3

Q37957047-2CF6C10F-6559-4B4B-BA38-FDCD73DC132E

Q37957047-2E60849A-DE70-44C3-8FE0-610751D02B1D

Q37957047-35E7A7E4-D5DC-4948-92E7-266373E0146F

Q37957047-3A87A84E-B557-4D7D-9A7C-C08C42DC5878

Q37957047-3E670A1B-D557-48E0-8CE3-FE225236585B

P2888

Q37957047-9BDB8DF5-E8BD-4C25-94E6-229C078F9DDD

P304

Q37957047-C81887E7-31AA-411B-B7DB-35786A8383A1

P31

Q37957047-D13879D5-0EF5-4537-9571-DF60C90AB1F0

P356

Q37957047-A4EE4A68-BE12-4809-AD4A-754EE3A2AC26

P433

Q37957047-5A1C86F7-BF09-442E-AA30-5A13EF6483D9

P478

Q37957047-2BD6B550-2813-4D6A-ABB2-0D37DA6B6005

P50

Q37957047-9491EB5B-0B23-43D4-B968-04D3285F97E2

P577

Q37957047-C4FB82EC-2188-4D58-A879-6FA947E0D522

P698

Q37957047-29B5F0B2-7C99-42EA-97AB-4F6642C9A3E1

P356

S12098-011-0608-5

P1433

Indian Journal of Pediatrics

P1476

Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?

@en

P2093

Bharti Balhara

http://www.w3.org/2001/XMLSchema#string

Lynne L Levitsky

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit

Growth hormone and health policy

IGFs and IGFBPs: role in health and disease.

Systemic and local regulation of the growth plate.

Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans.

Is there a role for recombinant insulin-like growth factor-I in the treatment of idiopathic short stature?

The role of the IGF system in cancer growth and metastasis: overview and recent insights.

The oncogenic potential of growth hormone.

Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?

The role of recombinant human insulin-like growth factor-I in treating children with short stature.

P2888

s12098-011-0608-5

P304

244-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-011-0608-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Madhusmita Misra

P577

2011-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22090255

http://www.w3.org/2001/XMLSchema#string